CLINICAL TRIAL MANAGEMENT Global PM Meeting, Philadelphia, USA Our Experience Instead of trying to be everything to everyone, we focus on doing what we know we do best. We See It Coming… A Word About Premier Start When you plan for something, it never catches you by surprise. We call our upfront planning process Premier Start. It’s designed to document and communicate all project deliverables and activities to the team in explicit detail. And we do work as a team—not a sponsor team and a Premier Research project team, but a single team that has the same understanding of recruitment goals, start-up dates and deliverables from first patient in to data lockup. It’s our way of focusing everyone’s efforts in the same direction. Communications are a key part of it, and two face-to-face meetings play a big role. n he Sponsor-Premier Research Kick-Off T Meeting gives the Premier Research Project Manager and team the opportunity to develop a clear, detailed understanding of the customer’s needs and requirements We offer a surprising concentration of experience for a mid-sized CRO: over 700 trials for virtually every major class of analgesic. Three times as many medical device studies as the world’s largest CRO. An unmatched record working in rare diseases. Pediatric experience with both familiar and extremely rare childhood illnesses, including a track record of successful neonatal studies. n he Study Start-Up Workshop allows everyone T involved to review in detail Premier Research’s draft study plans to ensure that all assumptions are realistic, all objectives are feasible, and all milestones can be met Because it’s better to see what’s coming when you still have time to avoid it. 1,000 We’re a nimble CRO of over 1,000 people with a remarkable ability to anticipate the unexpected. Three Valuable Tools to Consider Our customers are changing the face of medicine, and we’re right out there with them. Companion Diagnostics and Targeted Therapeutics. Premier Research’s Medical Device and Diagnostics team is a leader in using companion diagnostics to predict which individual patients will—and won’t—respond to a drug, and to determine optimal dosage. Adaptive Trial Design makes studies more efficient by reducing the time or number of patients required and accelerating the collection of significant data. At Premier Research, we don’t try to do everything for everyone. Instead, we focus on doing what we do best, collaborating with our customers—highly innovative small to mid-sized biopharmaceutical companies—to efficiently bring their life-changing developments from initial strategy through clinical development to final regulatory submission. We’re not so big that we’re going to tell you how to do your job. We’re not so small that we can’t do ours. We have worked on some amazing new medicinal products and devices, from simple Phase I studies in our own Clinical Research Centers to global trials involving multiple languages, hundreds of investigators and thousands of patients. North America: +1 215 282 5500 | Europe: +44 118 936 4000 | [email protected] premier-research.com ©2015 Premier Research 100 06/15
© Copyright 2024